Issue 23 | 2015
Get instant access to latest e-book

latest news


Nov 2015

Alliance Pharma says buys Sinclair IS Pharma's dermatology unit for £132 million

Sinclair IS Pharma plc the international specialty pharma company today announces the strategic disposal of its nonaesthetics business to Alliance Pharma plc the Disposal for a total upfront cash consideration of m m consideration plus cm for estimated stock at closing as well as salesrela..


Nov 2015

Denmark-Based Xellia Pharmaceuticals to open manufacturing center in Bedford, Ohio

Denmarkbased Xellia Pharmaceuticals a specialty pharmaceutical company focusing on providing important antiinfective treatments against serious and often lifethreatening infections has acquired manufacturing facilities in Bedford Ohio The facilities were bought from a wholly owned subsidiary of Hikma Pharmaceuticals Under the terms of the agreemen..


Nov 2015

Amgen files for U.S. approval of biosimilar to Humira

Amgen Inc on Wednesday said it filed with US health regulators seeking approval to sell its first biosimilar drug which would be a less expensive alternative to AbbVies Humira the worlds topselling prescription medicine Amgen said its drug ABP has demonstrated clinical equivalence and comparable safety to Humira adal..


Nov 2015

Allergan drops appeal of order blocking Alzheimer's drug switch

Allergan PLC said on Wednesday it will not appeal to the US Supreme Court a court ruling this year that blocked the company from discontinuing its topselling Alzheimers drug in favor of a pricier version Allergan will also pay in legal expenses under a settlement with New York Attorney General Eric Schneiderman who f..

events

24 - 27

Nov 2015

Pharmtech & Ingredients 2015

ITE Expo
Crocus Expo IEC, Moscow, Russia

01 - 02

Dec 2015


Nov 2015

Linden Care Responds To Court Ruling

WOODBURY NY Nov PRNewswire Linden Care LLC a r..


  • 2

    Pricing Pharmaceuticals in India

    The issue of striking an optimum level of drug pricing so as to favor both the customers as well as the producers has been one of the most volatile subjects at ..

knowledge bank

  • interviews

    ExpreS2ion Biotechnologies

    Vice President - Business Development
    ExpreS2ion Biotechnologies’ protein expression system ExpreS2 is an important protein expression tool in the scientist’s tool box for protein expression. The ExpreS2 platform has demonstrated i..

  • Articles

    Better ways to handle tablets using IBCs

    Still handling tablets in drums It is common to find Intermediate Bulk Containers IBCs being used for handling powders and granules in solid dosage manufacturing processes from initial Dispensing through to Tablet Compression or Capsule Filling The benefits of using IBCs for efficient and flexible materials handling at this stage of the process are widely appreciated and applied in modern facilit..

  • Research Insights

    Utilization of an Eilat Virus-Based Chimera for Serological Detection of Chikungunya Infection

    Abstract In December of chikungunya virus CHIKV an alphavirus in the family Togaviridae was introduced to the island of Saint Martin in the Caribbean resulting in the first autochthonous cases reported in the Americas As of January local and imported CHIKV has been reported in American countries with over million suspected cases CHIKV causes a severe arthralgic disease for which there are no approved vaccines or therapeutics Furthermore the ..

  • Case Studies

    Isolation Technology: Case Study

    A customer active in the hormone production recently searched an appropriate solution for grinding material and clean packaging after the filtering and drying process The following requirements had to be met bullTo provide a safe barrier between the operator and the active drug substance to provide both operator an..

editorial Section

  • Strategy


    The bioprinting of tissues and organs has been big news recently However the patenting of bioprinting techniques has quietly been going on for years This article will discuss the patents covering the three process phases of bioprinting the exceptions to patent infringement for experimental uses and the prospects for further patenting and patent infringement lawsuits..

  • Research Developement

    Rethinking Drug Discovery

    The quest to undertake biological targets that are based on the regulation of signalling pathways is challenging the classical thinking in the drug discovery arena Historically the complexity of the biological system was underestimated It is now wellaccepted that compared to old biological targets that were focused on single gene or gene products w..

  • Clinical Trails

    Issues & Concerns in Conducting Clinical Trials in India

    Issues like approval delays deficiencies of functioning of CROs and other stake holders liabilities and compensation to injured subjects insurance issues etc still remain in India which has made multinational companies to rethink on opting for India to conduct clinical trials in India recently There is a need for a law to ensure that the people who undergo clinical trials are not exploited and should be well informed about risk as well to provide..

  • Manufacturing

    Validation Projects in China

    This article is a firsthand account of the experiences of Pharmadule in guiding leading Chinese manufacturers through facility investment projects aimed at compliance with Chinese US and EU GMP requirements These manufacturers have been among the first in the world to fully embrace the work procedures outlined in ICH Q Q and Q Implementing these guidelines in large organisations would be a challen..

  • Information Technology

    Quality by Design

    The article presents a novel approach to applying Quality by Design QbD principles to the development of analytical methods Common critical parameters in HPLC gradient time temperature pH of the aqueous eluent and stationary phase are evaluated within the Quality by Design framework It is useful for the robust analytical method development and Design Space optimisation..

  • Expert Talk

    Peptides Remain a Growth Story

    Cloud solutions offer immediate returns in improving operational performance and reducing costs Multiple approaches to cloud solutions will be needed to satisfy life science industry needs complicating the development of a coherent cloud strategy..